The effect of alpha1-AR antagonists for lower urinary tract symptoms in patients undergoing prostate 125I brachytherapy for prostate carcinoma
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000005786
- Lead Sponsor
- Kinki University Faculty of Medicine
- Brief Summary
AUA-2011 Abstract No.2161 EAU-2012 Abstract No.732 World J Urol. 2014 Jan 17
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with allergy against Silodocin. Patient with neurogenic bladder, bladder neck constructure, urethral stenosis, vesical stone, or large bladder diverticulum. Patient with active urinary tract infection. Patient with severe renal dysfunction. Patient with severe liver disease. Patient who is considered to be inapropriate for this study by physisian.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IPSS total score
- Secondary Outcome Measures
Name Time Method Pressure flow study, I-PSS storage subscores, I-PSS voiding subscores ,QOL, OABSS, IIEF5, Uroflowmetry, PVR